Abacus Wealth Partners, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1978011
SANTA MONICA, CA
Position in HALO
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$440,324
-$27,276 QoQ
Shares Held
6,813
-1.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Abacus Wealth Partners, LLC holds $5,926,857 across 17 Biotechnology names. HALO ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,208 | $933,349 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,753 | $782,784 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
6,813 | $440,324 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
4,094 | $431,507 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
7,802 | $382,688 | |
| 6 | INSM |
INSMED Inc
|
2,338 | $382,309 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
24,599 | $364,557 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,836 | $359,121 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $440,324 | 6,813 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $467,600 | 6,948 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||